Amalgamated Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-353
Closed -$5K 3182
2024
Q1
$5K Sell
353
-1,129
-76% -$16K ﹤0.01% 2757
2023
Q4
$20K Sell
1,482
-105
-7% -$1.42K ﹤0.01% 2660
2023
Q3
$20K Hold
1,587
﹤0.01% 2669
2023
Q2
$20K Buy
+1,587
New +$20K ﹤0.01% 2755
2017
Q3
Sell
-2,091
Closed -$20K 1619
2017
Q2
$20K Buy
2,091
+170
+9% +$1.63K ﹤0.01% 1581
2017
Q1
$47K Buy
1,921
+1
+0.1% +$24 ﹤0.01% 1472
2016
Q4
$62K Buy
1,920
+254
+15% +$8.2K ﹤0.01% 1475
2016
Q3
$83K Buy
1,666
+7
+0.4% +$349 ﹤0.01% 1346
2016
Q2
$67K Buy
1,659
+108
+7% +$4.36K ﹤0.01% 1348
2016
Q1
$102K Buy
1,551
+150
+11% +$9.87K 0.01% 1221
2015
Q4
$87K Sell
1,401
-69
-5% -$4.29K 0.01% 1151
2015
Q3
$98K Buy
1,470
+23
+2% +$1.53K 0.01% 1241
2015
Q2
$141K Buy
+1,447
New +$141K 0.01% 1287
2014
Q1
Sell
-1,275
Closed -$54K 863
2013
Q4
$54K Buy
+1,275
New +$54K 0.01% 818